ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Program: Hughes Institute Official To Head Cancer Biology

July 23, 1999

Timeline Pinpoints the Role of Cancer Scandal In a Progression Leading to Perry’s Indictment

September 5, 2014

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

November 23, 2005

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995

IOM Selects Advisors To Defense Department

February 5, 1993

Studies Link Age-Dependent Outcome To Immune Cells

November 28, 2003